Bloomage Biotech(SH:688363) Tai Mei Ti A P P·2025-09-01 04:21Core Insights - AI² Robotics has recently completed a significant Series A financing round, raising several hundred million yuan, led by Shenzhen Capital Group with participation from existing shareholders and new investors [2][3]. Financing and Investment - The latest financing round is one of the largest among the seven rounds of several hundred million yuan completed by the company in the past six months [3]. - The funds will be utilized for the continuous iteration of the GOVLA large model and the AlphaBot series robots, as well as for expanding production lines and global market development [3]. Company Overview - AI² Robotics was founded in early 2023, focusing on general-purpose embodied robotic brains, integrating hardware and software to deliver intelligent robotic products, solutions, and services [3]. - The founder and CEO, Guo Yandong, has a strong background in AI, having worked with major companies like Microsoft and Xpeng Motors, and aims to develop the next generation of robots with "embodied intelligent brains" [3][4]. Technological Advancements - The company emphasizes a "soft and hard integration" approach, with its Alpha Bot series already entering the automotive manufacturing sector, competing directly with Tesla's Optimus [3]. - AI² Robotics has pioneered the end-to-end VLA (Vision-Language-Action) technology and released the world's first comprehensive VLA large model (GOVLA), which enhances perception and control capabilities [4]. - The company has achieved significant performance improvements, surpassing international benchmarks by 30% in evaluations [4]. Market Outlook - Guo Yandong believes that the mass production of humanoid robots is not yet fully mature, with component production still needing development, but anticipates that as demand grows, the industry will reach maturity [5]. - The vision is to make general-purpose intelligent robots as ubiquitous as smart cars and smartphones, with a timeline of 5-7 years for a significant breakthrough in the humanoid robot market [5].